An Investigation To Determine The Potential Interaction Effect Between GW876008 And Midazolam.

NCT00423761 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2009-05-18

No results posted yet for this study

Summary

This study will evaluate any effect of single and repeated administration of GW876008 on the metabolism of midazolam in healthy volunteers.

Conditions

  • Healthy Subjects

Interventions

DRUG

midazolam

DRUG

GW876008

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials, MBChB, MFPM · GlaxoSmithKline

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00423761 on ClinicalTrials.gov